EUVIMEDEUVIMED entdecken
Crossref

Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors- initial experience of single center

Y. Petkova, P. Karagyozov, N. Shumka

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S402-S403

DOI: 10.1055/s-0044-1783701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von Y. Petkova und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The mainstay treatment for pancreatic tumors is surgery. However adverse events and post -operative mortality are a concerning issue. Endoscopic ultrasound-guided radiofrequency ablation/EUS RFA/ is a novel technique for local destruction, applicable for pancreatic neuroendocrine tumors /PanNEN/, locally advanced adenocarcinoma and cystic pancreatic neoplasms.Our aim was to evaluate the technique in terms of efficacy and safety. Primary endpoint was complete response rate defined as disappearance of lesions or no signs of vital tissue on imaging studies during follow up. The secondary endpoint was the assessment of adverse events/AE/ associated with the procedure.

Methods

Retrospective analysis of a prospective database including all consecutive patients who were treated with EUS RFA for the period August 2022 – October 2023 in a single tertiary center. We evaluated electronic patient records and gathered data on patients' baseline characteristics, procedure characteristics and outcomes.The follow up of the group included imaging studies/computed tomography and contrast enhanced EUS/ done on the third and on the sixth month after the procedure.

Results

Eight sessions of RFA in five patients were performed. Male to-female ratio 3:2, the mean age was 72.2 years. The procedures were performed with EUS–guided RFA 19 G Needle. The group included three patients with neuroendocrine tumors – two with non-functional pNEN – G1 grade of differentiation and one with insulinoma;one patient with metastasis from renal cell carcinoma, and one patient with pancreatic ductal adenocarcinoma. The mean size of the lesions was 22mm±10.06mm. The technical success rate which we defined as successful puncture of the lesion and application of alternating current was 100%. Clinical success at the 6 th month was achieved in 80% of the patients. In three of the patients, we performed a second session on the third month during follow-up. We found no correlation between response rate and functional status of neuroendocrine tumors as well as no association of procedure outcome and location of lesions. In terms of efficacy, we found a negative correlation between lesion size and response rate. We observed the resolution of symptoms due to hormonal hypersecretion in the case of insulinoma in the first 24 postprocedural hours with no events of hypoglycemia. No early or late adverse events were reported in the observed group Conclusions EUS RFA is highly effective and safe mini-invasive technique for treating pancreatic tumors, especially PanNENs.It could be offered to selected patients as an alternative to surgical treatment for patients with neuroendocrine tumors and cystic lesions according to published studies.The procedure can be applied as an adjunctive treatment to locally advanced ductal adenocarcinoma but more data are needed. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Petkova, Y., Karagyozov, P., & Shumka, N. (2024). Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors- initial experience of single center. Endoscopy, 56(S 02 S 02), S402-S403. https://doi.org/10.1055/s-0044-1783701

Vancouver

Petkova Y, Karagyozov P, Shumka N. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors- initial experience of single center. Endoscopy. 2024;56(S 02 S 02):S402-S403. doi:10.1055/s-0044-1783701

BibTeX
@article{Petkova2024,
  author = {Petkova, Y. and Karagyozov, P. and Shumka, N.},
  title = {Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors- initial experience of single center},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S402--S403},
  doi = {10.1055/s-0044-1783701}
}
Kostenlos starten →